Skip to content

Application of CD44v6 labeled near infrared probe in diagnosis and treatment of bladder cancer

Application of CD44v6 labeled near infrared probe in diagnosis and treatment of bladder cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17012616
Enrollment
Unknown
Registered
2017-09-07
Start date
2017-09-07
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

Gold Standard:cyctoscopy combined with unrine cystology
&#32
tumor&#32
to&#32

Sponsors

The Fourth Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patient has fully understand and voluntarily signed written informed consent; 2. The pathologic diagnosis is diagnosed and surgical treatment is to performed; 3. Aged 18-70 years old, male or female; 4. KPS score=60; 5. The functions of organs are basically normal (In the absence of continuous support treatment, laboratory test results in the first week of the group were enrolled): neutrophil>1.5×10^9/L, blood platelet>100×10^9/L, hemoglobin>9.0g/dl, bilirubin < 1.5×UL, NAST(SGOT), ALT(SGPT)<2.5×ULN, serum creatinine<1.5× ULN=3 months 6. Expected survival.

Exclusion criteria

Exclusion criteria: 1. Cystonisis; 2. Urological deformity or urethral stricture; 3. white blood cells<1.5×10^9/L or neutrophil<1.0×10^9 /L; 4. pregnancy or lactation period; 5. Patients with serious diseases of other systems; 6. Allergy to a variety of drugs; 7. Participated in or participated in another clinical study in 30 days; 8. Patient's adherence to this clinical study is insufficient.

Design outcomes

Primary

MeasureTime frame
Fluorescence intensity;Tumor to background ratio;

Countries

China

Contacts

Public ContactWanhai Xu

The Fourth Hospital of Harbin Medical University

xuwanhai@163.com+86 13313602566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026